Salisu Abubakar1, Garba Iliyasu2, Farouq Muhammad Dayyab3, Salisu Inuwa4, Rabiu Alhassan Tudun Wada4, Nasiru Magaji Sadiq5, Muktar Ahmed Gadanya6, Abdulrahman Abba Sheshe7, Mohammad Sani Mijinyawa8, Abdulrazaq Garba Habib2. 1. Department of Nursing, College of Health Sciences, Bayero University Kano, Kano, Nigeria. 2. Infectious and Tropical Diseases Unit, Department of Medicine, College of Health Sciences, Bayero University Kano, Kano, Nigeria. 3. Infectious and Tropical Diseases Unit, Department of Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria. 4. Infection Control Unit, Aminu Kano Teaching Hospital, Kano, Nigeria. 5. Department of Microbiology and Parasitology, Aminu Kano Teaching Hospital, Kano, Nigeria. 6. Department of Community Medicine, College of Health Sciences, Bayero University Kano, Kano, Nigeria. 7. Department of Surgery, College of Health Sciences, Bayero University Kano, Kano, Nigeria. 8. Department of Medicine, College of Health Sciences, Bayero University Kano, Kano, Nigeria.
Abstract
BACKGROUND: Healthcare workers (HCWs) have an increased risk of occupational exposure to blood-borne pathogens. AIMS/ OBJECTIVES: We aim to examine the utilisation and outcome of post-exposure prophylaxis (PEP) for both HIV and hepatitis B (HBV) among HCWs. METHODS: This was a retrospective study conducted in a tertiary hospital in North-Western Nigeria. We reviewed data on HIV or HBV PEP given to HCWs between 2004 and 2016. RESULTS: A total of 115 HCWs presented for PEP during the study period. Intern doctors were the most exposed group (40/115; 34.8%). There were 86/115 (74.8%) needle stick exposures. While 53/115 (46.1%) of the sources of exposure were HIV-positive, 9/115(7.83%) were HBV-positive. Zidovudine-based regimen (40/70) was the most commonly prescribed. No seroconversion occurred among those that completed PEP treatment and follow-up. DISCUSSION: No seroconversion occurred among those that received either or both HIV and HBV PEP and completed PEP treatment.
BACKGROUND: Healthcare workers (HCWs) have an increased risk of occupational exposure to blood-borne pathogens. AIMS/ OBJECTIVES: We aim to examine the utilisation and outcome of post-exposure prophylaxis (PEP) for both HIV and hepatitis B (HBV) among HCWs. METHODS: This was a retrospective study conducted in a tertiary hospital in North-Western Nigeria. We reviewed data on HIV or HBV PEP given to HCWs between 2004 and 2016. RESULTS: A total of 115 HCWs presented for PEP during the study period. Intern doctors were the most exposed group (40/115; 34.8%). There were 86/115 (74.8%) needle stick exposures. While 53/115 (46.1%) of the sources of exposure were HIV-positive, 9/115(7.83%) were HBV-positive. Zidovudine-based regimen (40/70) was the most commonly prescribed. No seroconversion occurred among those that completed PEP treatment and follow-up. DISCUSSION: No seroconversion occurred among those that received either or both HIV and HBV PEP and completed PEP treatment.
Entities:
Keywords:
Human immunodeficiency virus (HIV); infection control; vaccination
Authors: Shilpa M Patel; Stuart Johnson; Steven M Belknap; Juliana Chan; Beverly E Sha; Charles Bennett Journal: J Acquir Immune Defic Syndr Date: 2004-02-01 Impact factor: 3.731
Authors: D M Cardo; D H Culver; C A Ciesielski; P U Srivastava; R Marcus; D Abiteboul; J Heptonstall; G Ippolito; F Lot; P S McKibben; D M Bell Journal: N Engl J Med Date: 1997-11-20 Impact factor: 91.245
Authors: J I Tokars; R Marcus; D H Culver; C A Schable; P S McKibben; C I Bandea; D M Bell Journal: Ann Intern Med Date: 1993-06-15 Impact factor: 25.391
Authors: Nathan Ford; Cadi Irvine; Zara Shubber; Rachel Baggaley; Rachel Beanland; Marco Vitoria; Meg Doherty; Edward J Mills; Alexandra Calmy Journal: AIDS Date: 2014-11-28 Impact factor: 4.177
Authors: John Bosco Isunju; Solomon Tsebeni Wafula; Rawlance Ndejjo; Rebecca Nuwematsiko; Pamela Bakkabulindi; Aisha Nalugya; James Muleme; Winnie Kansiime Kimara; Simon P S Kibira; Joana Nakiggala; Richard K Mugambe; Esther Buregyeya; Tonny Ssekamatte; Rhoda K Wanyenze Journal: PLoS One Date: 2022-06-23 Impact factor: 3.752
Authors: Bilkisu Z Iliyasu; Taiwo G Amole; Hadiza S Galadanci; Shahida S Abdullahi; Zubairu Iliyasu; Muktar Hassan Aliyu Journal: Int J Occup Environ Med Date: 2020-10